🤖 AI Summary
Johnson & Johnson’s Michel, who leads the EMEA data science team, is set to participate in the Pharma AI Exchange series hosted by deepsense.ai. The discussion will focus on the integration of AI in evidence generation, clinical planning, and achieving launch readiness within the pharmaceutical sector. Michel's experience with European health data initiatives like EHDEN, EMIF, and HARMONY highlights his expertise in connecting fragmented data for improved research and decision-making, which is crucial for ensuring reliable AI applications in the industry.
The significance of this conversation lies in the collaboration between industry leaders and AI practitioners to explore practical use cases and real-world applications of AI in healthcare. The series aims to tackle essential topics such as R&D, market access, and clinical operations while addressing organizational and technical challenges involved in implementing AI solutions. By sharing insights on valuable use cases, the conversation will guide pharma professionals in making informed AI investments and shaping effective initiatives, ultimately emphasizing the need for reliability and governance in AI adoption within complex and regulated environments.
Loading comments...
login to comment
loading comments...
no comments yet